Steven Sell - 14 Apr 2023 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Role
CEO & President, Director
Signature
/s/ Steve Meetre, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2023
Net transactions value
-$119,987
Form type
4/A - Amendment
Filing time
16 Jun 2023, 16:29:19 UTC
Date Of Original Report
18 Apr 2023
Previous filing
22 Nov 2022
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +39,530 +81% $0.000000 88,295 14 Apr 2023 Direct F1, F2, F3
transaction AGL Common Stock Tax liability $119,987 -4,216 -4.8% $28.46 84,079 14 Apr 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Award $0 +68,348 $0.000000 68,348 14 Apr 2023 Common Stock 68,348 $28.46 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
F2 This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A.
F3 Includes restricted stock units.
F4 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F5 The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A.
F6 Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.